Keyphrases
Acute Myeloid Leukemia
100%
Dehydrogenase
100%
Therapeutic Vulnerabilities
100%
α-ketoglutarate (α-KG)
100%
Tricarboxylic Acid Cycle (TCA cycle)
28%
Nucleotide Biosynthesis
28%
2-oxoglutarate Dehydrogenase
28%
Ketoglutarate Dehydrogenase Complex
28%
Specific Vulnerability
28%
Functional Genomics
14%
Mouse Model
14%
Metabolic
14%
Metabolism
14%
Therapeutic Targeting
14%
Metabolomics
14%
Cancer-specific
14%
Genomic Models
14%
Wiring
14%
Aspartate
14%
Coenzyme A
14%
Intermediary Metabolism
14%
Functional Links
14%
Multiple Models
14%
Key Amino Acids
14%
Cellular Bioenergetics
14%
Adverse Risk
14%
Biosynthesis Enzymes
14%
Leukemia Progression
14%
Metabolic Nodes
14%
Biochemistry, Genetics and Molecular Biology
Dehydrogenase
100%
Myeloid
100%
Oxidoreductase
100%
Metabolic Pathway
28%
Citric Acid Cycle
28%
Nucleotide Metabolism
28%
Anabolism
14%
Mouse Model
14%
Functional Genomics
14%
Amino Acids
14%
Enzyme
14%
Metabolomics
14%
Bioenergetics
14%
Aspartic Acid
14%
Coenzyme A
14%
Neuroscience
Myeloid
100%
Oxoglutarate Dehydrogenase
100%
Anabolism
42%
Metabolic Pathway
28%
Citric Acid Cycle
28%
Amino Acid
14%
Aspartic Acid
14%
Functional Genomics
14%
Succinyl Coenzyme A
14%
Medicine and Dentistry
Acute Myeloid Leukemia
100%
Oxoglutarate Dehydrogenase
100%
Nucleotide Metabolism
28%
Citric Acid Cycle
28%
Malignant Neoplasm
14%
Metabolomics
14%
Cancer
14%
Functional Genomics
14%
Amino Acid
14%
Aspartic Acid
14%
Succinyl-CoA
14%
Pharmacology, Toxicology and Pharmaceutical Science
Oxoglutarate Dehydrogenase
100%
Acute Myeloid Leukemia
100%
Tricarboxylic Acid
28%
Mouse Model
14%
Malignant Neoplasm
14%
Amino Acid
14%
Succinyl-CoA
14%
Aspartic Acid
14%